These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

299 related items for PubMed ID: 25122903

  • 1. A heroin addiction severity-associated intronic single nucleotide polymorphism modulates alternative pre-mRNA splicing of the μ opioid receptor gene OPRM1 via hnRNPH interactions.
    Xu J, Lu Z, Xu M, Pan L, Deng Y, Xie X, Liu H, Ding S, Hurd YL, Pasternak GW, Klein RJ, Cartegni L, Zhou W, Pan YX.
    J Neurosci; 2014 Aug 13; 34(33):11048-66. PubMed ID: 25122903
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Sequence variations in the mu-opioid receptor gene (OPRM1) associated with human addiction to heroin.
    Shi J, Hui L, Xu Y, Wang F, Huang W, Hu G.
    Hum Mutat; 2002 Apr 13; 19(4):459-60. PubMed ID: 11933204
    [Abstract] [Full Text] [Related]

  • 4. Epistatic effects between variants of kappa-opioid receptor gene and A118G of mu-opioid receptor gene increase susceptibility to addiction in Indian population.
    Kumar D, Chakraborty J, Das S.
    Prog Neuropsychopharmacol Biol Psychiatry; 2012 Mar 30; 36(2):225-30. PubMed ID: 22138325
    [Abstract] [Full Text] [Related]

  • 5. A single nucleotide polymorphism in OPRM1(rs483481) and risk for heroin use disorder.
    Koijam AS, Chakraborty B, Mukhopadhyay K, Rajamma U, Haobam R.
    J Addict Dis; 2020 Mar 30; 38(2):214-222. PubMed ID: 32189578
    [Abstract] [Full Text] [Related]

  • 6. Expansion of the human mu-opioid receptor gene architecture: novel functional variants.
    Shabalina SA, Zaykin DV, Gris P, Ogurtsov AY, Gauthier J, Shibata K, Tchivileva IE, Belfer I, Mishra B, Kiselycznyk C, Wallace MR, Staud R, Spiridonov NA, Max MB, Goldman D, Fillingim RB, Maixner W, Diatchenko L.
    Hum Mol Genet; 2009 Mar 15; 18(6):1037-51. PubMed ID: 19103668
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Genotype patterns that contribute to increased risk for or protection from developing heroin addiction.
    Nielsen DA, Ji F, Yuferov V, Ho A, Chen A, Levran O, Ott J, Kreek MJ.
    Mol Psychiatry; 2008 Apr 15; 13(4):417-28. PubMed ID: 18195715
    [Abstract] [Full Text] [Related]

  • 9. Genetic susceptibility to heroin addiction: a candidate gene association study.
    Levran O, Londono D, O'Hara K, Nielsen DA, Peles E, Rotrosen J, Casadonte P, Linzy S, Randesi M, Ott J, Adelson M, Kreek MJ.
    Genes Brain Behav; 2008 Oct 15; 7(7):720-9. PubMed ID: 18518925
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Contribution of Genetic Polymorphisms and Haplotypes in DRD2, BDNF, and Opioid Receptors to Heroin Dependence and Endophenotypes Among the Han Chinese.
    Gao X, Wang Y, Lang M, Yuan L, Reece AS, Wang W.
    OMICS; 2017 Jul 15; 21(7):404-412. PubMed ID: 28692418
    [Abstract] [Full Text] [Related]

  • 12. Functional mu opioid receptor polymorphism (OPRM1 A(118) G) associated with heroin use outcomes in Caucasian males: A pilot study.
    Woodcock EA, Lundahl LH, Burmeister M, Greenwald MK.
    Am J Addict; 2015 Jun 15; 24(4):329-35. PubMed ID: 25911999
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. The μ-opioid receptor nonsynonymous variant 118A>G is associated with prolonged abstinence from heroin without agonist treatment.
    Levran O, Peles E, Randesi M, da Rosa JC, Adelson M, Kreek MJ.
    Pharmacogenomics; 2017 Oct 15; 18(15):1387-1391. PubMed ID: 28976288
    [Abstract] [Full Text] [Related]

  • 15. Association of μ-opioid receptor gene (OPRM1) haplotypes with postoperative nausea and vomiting.
    Sugino S, Hayase T, Higuchi M, Saito K, Moriya H, Kumeta Y, Kurosawa N, Namiki A, Janicki PK.
    Exp Brain Res; 2014 Aug 15; 232(8):2627-35. PubMed ID: 24858579
    [Abstract] [Full Text] [Related]

  • 16. ELK1 transcription factor linked to dysregulated striatal mu opioid receptor signaling network and OPRM1 polymorphism in human heroin abusers.
    Daws SE, Whittard JD, Jacobs MM, Ren Y, Mazloom AR, Caputi FF, Horvath M, Keller E, Ma'ayan A, Pan YX, Chiang LW, Hurd YL.
    Biol Psychiatry; 2013 Oct 01; 74(7):511-9. PubMed ID: 23702428
    [Abstract] [Full Text] [Related]

  • 17. Mouse model of the OPRM1 (A118G) polymorphism: differential heroin self-administration behavior compared with wild-type mice.
    Zhang Y, Picetti R, Butelman ER, Ho A, Blendy JA, Kreek MJ.
    Neuropsychopharmacology; 2015 Mar 13; 40(5):1091-100. PubMed ID: 25336208
    [Abstract] [Full Text] [Related]

  • 18. Effect of mu-opioid receptor gene polymorphisms on heroin-induced subjective responses in a Chinese population.
    Zhang D, Shao C, Shao M, Yan P, Wang Y, Liu Y, Liu W, Lin T, Xie Y, Zhao Y, Lu D, Li Y, Jin L.
    Biol Psychiatry; 2007 Jun 01; 61(11):1244-51. PubMed ID: 17157823
    [Abstract] [Full Text] [Related]

  • 19. Genetic-epigenetic interaction modulates μ-opioid receptor regulation.
    Oertel BG, Doehring A, Roskam B, Kettner M, Hackmann N, Ferreirós N, Schmidt PH, Lötsch J.
    Hum Mol Genet; 2012 Nov 01; 21(21):4751-60. PubMed ID: 22875838
    [Abstract] [Full Text] [Related]

  • 20. Haplotype block structure of the genomic region of the mu opioid receptor gene.
    Levran O, Awolesi O, Linzy S, Adelson M, Kreek MJ.
    J Hum Genet; 2011 Feb 01; 56(2):147-55. PubMed ID: 21160491
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.